Trial Condition(s):

Atopic dermatitis

Dermatology II

Bayer Identifier:

1400402

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

249

Trial Dates

July2005

June2006

Phase

Could I receive a placebo?

Products

Advantan (Methylprednisolone Aceponate, BAY86-4862)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Atopic dermatitis

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

12 Years

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information